Abstract:Vascular endothelial growth factor plays an important role in neovascularization both in normal tissues and most tumors. It has been extensively investigated recently in various hepatic diseases such as primary and secondary hepatocellular carcinoma, liver cirrhosis, hepatitis and even benign tumors in liver. Vascular endothelial growth factor has been verified to be closely involved in the development and metastases of hepatocellular carcinoma and correlated to the high risk of hepatic metastases and a poor prognosis in gastrointestinal cancer. Using antibodies to vascular endothelial growth factor or other drugs to suppress its expression has also been successfully tried to restrain hepatocellular carcinoma cells and metastases in vitro and in animal models. The protein of vascular endothelial growth factor has an inclination to increase in acute and chronic hepatitis and tends to decrease in cirrhosis both in tissue expression and circulating levels. This circulating level is closely related to the Child-Pugh classification in cirrhotic liver. However, there are indeed some disagreements concerning vascular endothelial growth factor and liver disease, for example, opinions on the positive rates of vascular endothelial growth factor in protein and mRNA level are far from reaching a general consensus. Further study should be performed in the future in antitumor research and its significance in the process of liver cirrhosis.

Progress of Research on HGF/SF

HGF/c-Met Axis: the Advanced Development in Digestive System Cancer

Research Progress on Cancer-Associated Fibroblasts in Hepatocellular Carcinoma

Progress in Effects of the HGF/SF-c-Met on Progression of Tumors and Inhibitors of Its Pathway

HGF/c-Met: A Key Promoter in Liver Regeneration

Progress in researches of hepatocyte growth factor and its receptor for new drug development

[Research Progress of HGF/c-MET Inhibitor in the Treatment of Non-small Cell Lung Cancer].

Role of HGF/c‐Met in the treatment of colorectal cancer with liver metastasis

Role of HGF/c-Met Signaling in Tumorigenesis and the Tumor Therapy Therewith

Progress in Human Epidermal Growth Factor Research

Research Progress of C-Met Signaling Pathway and Antagonists

Diverse and Potent Activities of HGF/SF in Skin Wound Repair

Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review

Role of C-Met in the Progression of Human Oral Squamous Cell Carcinoma and Its Potential As a Therapeutic Target.

Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancers.

Vascular Endothelial Growth Factors and Liver Diseases.

Influence of Hepatocyte Growth Factor Scatter Factor on the Metastatic Phenotype of B16 Melanoma Cells

Research Progress on Biological Functions of Hepatocyte Growth Factor During Muscle Development

Research Progress of the Relationship Between HGF/Met and Invasion of Thyroid Carcinoma

[Advances in Mesenchymal to Epithelial Transition Factor Signaling Pathway and Inhibitors].

Advancement of the relationship between vascular endothelial growth factor receptors and angiogenesis of hepatocellular carcinoma